Connecting brain science & business

Sigrid Marie Blom joins NNN as Project Manager. Sigrid has research experience from both industry and academia.

New studies published in Science found that a drug thought to greatly reduce Alzheimer's symptoms is not as efficient as previously reported. 

On May 24, Aftenposten advertised the Norwegian Heath Industry Conference (Helseindustrikonferansen), which takes place in Oslo on June 6. The main article was about dementia and the story was based on statements by Professor Lars Nilsson at the Dept. of Pharmacology, University of Oslo and Nansen Neuroscience Network CEO Leif Rune Skymoen.